Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as a dermatology medicine in the United Kingdom. This page is a literature-context overview of compound families discussed in published dermatology research. It is not personal-use guidance. Peptides Lab UK supplies research-use-only laboratory reference compounds. Products are not for human or veterinary use.
Quick research summary. The published dermatology research literature spans skin biology, dermal wound healing, fibrosis pathways, pigmentation biology, and skin ageing mechanisms. Several peptide families appear in this research record. Topical cosmetic peptide products are sold separately under cosmetics regulation by other retailers.
Dermatology biology context
Skin-biology literature covers the epidermis (keratinocyte biology, barrier function), the dermis (fibroblast biology, extracellular matrix, dermal wound healing), the pigmentation system (melanocyte biology), the immune compartment (Langerhans cells, T-cell skin homing) and the appendages (hair follicle, sebaceous gland, sweat gland). Each axis has substantial peer-reviewed literature.
Compound families that appear in the published dermatology research record
Cell-culture and animal-model studies have discussed copper peptides such as GHK-Cu in fibroblast and dermal-matrix research, matrikine peptides in dermal repair research, melanocortin-system peptides in pigmentation biology, and several antimicrobial peptide families in skin host-defence research.
The cosmetic vs research-use distinction
Topical cosmetic products containing some of these peptide families are sold under cosmetics regulation by other retailers and may make cosmetic claims only. Peptides Lab UK supplies research-use-only laboratory reference compounds, not cosmetic products. The two regulatory contexts are different.
Where licensed UK dermatology medicines fit
Licensed UK dermatology treatment is delivered through NHS dermatology services using a wide range of MHRA-licensed prescription medicines (topical corticosteroids, calcineurin inhibitors, biologics for severe inflammatory skin disease, and many others). None of these are research-use-only peptide reference compounds.
UK regulatory position
No research-use-only peptide on this site is a licensed dermatology medicine in the UK. The MHRA opened investigations in April 2026 into UK clinics making therapeutic claims about unregulated peptide products.
For laboratory researchers
Dermatology researchers may use peptide reference compounds in in-vitro and ex-vivo skin model studies. Quality requirements are batch-specific certificate of analysis, third-party HPLC purity data, mass-spectrometry identity confirmation, and clear research-use-only labelling.
Research use only. Peptides Lab UK supplies research-use-only laboratory reference compounds with batch-specific certificates of analysis. Products are not for human or veterinary use.
